

Henkel's preferred share has spent much of the past five years as a fundamentally solid but often underperforming "self-help" and later "turnaround" story, with sentiment improving again after restructuring and integration progress.
2019–Early 2020: Late-Cycle Defensive, Then COVID Shock
In 2019 Henkel was viewed as a mature consumer and industrial group with slowing growth, pressured especially in Beauty Care and Laundry & Home Care. Investors increasingly framed it as a potential value trap versus faster-growing peers.
Management began emphasizing a "purposeful growth" agenda and efficiency measures, but market reaction was muted as organic growth lagged best-in-class consumer staples and adhesives peers.
When COVID-19 hit in early 2020, Henkel's adhesives exposure to autos and industrials, along with some discretionary consumer products, led to an initial sharp drawdown similar to cyclical names, despite part of the portfolio being defensive household products. The narrative shifted temporarily toward "cyclical COVID loser with some staples cushion," with investors focusing on the depth of industrial end-market weakness and operational leverage in Adhesive Technologies.
Mid-2020–2021: Recovery, But Underwhelming Turnaround
As global industrial production and auto volumes recovered from mid-2020 into 2021, Henkel's adhesives business rebounded and organic sales growth improved, helping earnings recover from the pandemic shock. Nonetheless, margin and growth momentum lagged leading consumer staples, and external commentary described Henkel as a turnaround story that was "not fully priced in" yet still trading at a discount to peers.
Through 2021 the stock participated in the broader recovery but underperformed high-quality consumer and specialty chemicals names. Henkel's chart showed a rebound from 2020 lows into 2021 followed by a stall and subsequent decline of roughly a quarter from mid-2021 levels. The perception settled into "slow-moving restructuring/turnaround" rather than a high-conviction compounder, with investors worried about persistent underperformance in Beauty Care and brand investment needs.
2022: Inflation Shock, Margin Pressure, Deep Value Narrative
In 2022 Henkel faced strong cost inflation in raw materials, energy and logistics, which squeezed margins and forced significant price increases across Adhesive Technologies and consumer brands. Earnings and guidance reflected this pressure, and investors focused on whether pricing power would fully offset costs. Henkel increasingly traded as a "deep value, margin-recovery" story instead of a stable defensive.
The share price trended lower and then moved mostly sideways, reflecting concerns over Europe's energy crisis, industrial demand, and the ability to execute on restructuring while protecting volumes. Technically, 2022 was characterized by a downtrend from early-year levels into mid-year, followed by a broad range-bound phase where rallies toward prior highs repeatedly failed, reinforcing the value-trap narrative.
2023–2024: Consumer Brands Integration and Margin Rebuild
Henkel accelerated portfolio restructuring, combining Laundry & Home Care and Beauty Care into a single Consumer Brands unit and exiting or pruning weaker brands, positioning the group around adhesives and a streamlined consumer portfolio. As pricing, mix improvement and savings from the Consumer Brands integration flowed through, profitability began to recover, and management communicated clearer financial targets under the "purposeful growth" agenda, shifting perception toward a more credible self-help story.
By 2024 Henkel reported "very good" annual results: solid organic sales growth, a margin increase of 2.4 percentage points, and a roughly 25% jump in earnings per preferred share, clearly above the low point during the inflation shock. These results, alongside portfolio optimization and cost savings, helped improve investor sentiment from "structural laggard" toward "improving quality turnaround," with some re-rating expectation but still at a discount to best-in-class staples and specialty chemical peers.
On the chart, 2023–2024 saw a transition from the prior downtrend and range into a more constructive phase with higher lows as earnings visibility improved and macro fears moderated, though rallies remained capped below pre-COVID peak multiples. Breakouts following key earnings or guidance updates tended to fade into consolidation, reflecting lingering skepticism and positioning Henkel more as a steady recovery than a momentum favorite.
2024–Early 2026: From Recovery to Re-Rated Defensive
The half-year 2024 report and subsequent full-year communication reinforced that the Consumer Brands integration and price/mix strategy were working, with strong gross margin gains and clear EPS leverage from restructuring. This bolstered a narrative of Henkel as a more focused, margin-accretive defensive compounder in the making, though still exposed to industrial cycles via Adhesive Technologies and to consumer demand normalization after large price increases.
Into late 2024 and early 2026, investors increasingly framed Henkel as a "quality turnaround with improving moat" rather than a pure value trap, with attention on sustaining mid-single-digit organic growth and high-teens margins over the cycle. The stock price over this phase reflected a gradual grind higher with intermittent pullbacks around macro headlines and industrial data, consistent with a chart dominated by step-ups around results followed by sideways consolidations rather than violent trend reversals.
Henkel AG & Co. KGaA operates across adhesives, laundry and home care, and beauty care—markets where it holds genuinely strong positions against other large FMCG and specialty chemical players.[1][8][12] The competition here is relentless. Global multinationals, regional brands, and private labels all push hard on price and innovation, which keeps pressure on Henkel's core categories.[7][8][12] The margin story matters most. Raw material costs swing around, chemicals and packaging face tighter regulation, and industrial demand for adhesives moves with economic cycles—all of which reshape profitability in ways the company can't entirely control.[4][7][14] That said, Henkel has real advantages in scale and brand equity. Staying ahead means constant work on innovation, sustainability, and operational efficiency to hold ground and keep margins intact.[2][4][7]
HEN3.XETRA represents Henkel AG & Co. KGaA's non-voting preferred shares. The company operates across adhesives, laundry and home care, and beauty care—a genuinely diversified portfolio that spans both consumer and specialty chemical markets. It's a crowded space. Henkel faces entrenched competitors with stronger brands, deeper global distribution, and marketing firepower that's hard to match. The real pressures come from three directions: competitive intensity that never really lets up, exposure to raw material and energy costs that swing unpredictably, and the ongoing transformation the company is working through. Add macro uncertainty, geopolitical tensions, and supply chain friction, and you've got a business where earnings and cash flows can move around more than you'd like. Worth watching, but with eyes open.
| Company | Ticker |
|---|---|
| The Procter & Gamble Company | PG.NYSE |
| Unilever PLC | ULVR.LSE |
| Reckitt Benckiser Group PLC | RKT.LSE |
| L'Oréal S.A. | OR.EPA |
| Coty Inc. | COTY.NYSE |
| Johnson & Johnson | JNJ.NYSE |
| H.B. Fuller Company | FUL.NYSE |
| Bostik SA (Arkema Group) | AKE.EPA |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial| Period | Henkel AG & Co. KGaA vz. (Pref Shares) | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +8.98% | +8.58% | +9.79% |
| 3M | +17.68% | +13.77% | +16.67% |
| 6M | +11.51% | +7.09% | +4.27% |
| 1Y | +0.14% | -9.11% | -16.74% |
| 3Y | +26.61% | -31.54% | -50.05% |
| 5Y | +10.54% | -64.45% | -82.24% |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHow the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 16.2 | 1.6 | 1.7 | 12.5 |
| 1Y ago | 10.5 | 0.8 | 1.6 | 5.5 |
| 3Y ago | 23.2 | 1.3 | 1.5 | 15.7 |
| 5Y ago | 25.7 | 1.9 | 1.8 | 7.9 |
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2025 | 2.04 EUR | 2.97% | 1.96% |
| 2024 | 1.85 EUR | 2.50% | |
| 2023 | 1.85 EUR | 2.49% | |
| 2022 | 1.85 EUR | 3.06% | |
| 2021 | 1.85 EUR | 1.87% | |
| 2020 | 1.85 EUR | 2.17% | |
| 2020 | 1.85 EUR | 2.35% | |
| 2019 | 1.85 EUR | 2.04% | |
| 2018 | 1.79 EUR | 1.67% | |
| 2017 | 1.62 EUR | 1.32% | |
| 2016 | 1.47 EUR | 1.49% | |
| 2015 | 1.31 EUR | 1.14% | |
| 2014 | 1.22 EUR | 1.55% | |
| 2013 | 0.95 EUR | 1.30% | |
| 2012 | 0.80 EUR | 1.44% |
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue | 21.59B | 21.51B | 22.40B | 20.07B | 19.25B |
| Operating income (EBIT) | 2.83B | 2.01B | 2.15B | 2.58B | 2.24B |
| Net income | 2.01B | 1.32B | 1.26B | 1.63B | 1.41B |
| Free cash flow | 2.49B | 2.65B | 654.00M | 1.49B | 2.37B |
| Total assets | 35.27B | 31.73B | 33.18B | 32.67B | 30.24B |
| Equity | 21.73B | 19.92B | 20.08B | 20.80B | 19.59B |
| Net debt | 1.40B | 936.00M | 2.47B | 842.00M | 1.47B |